The role of the class II transactivator (CIITA) in MHC class I and II regulation and graft rejection in kidney

被引:13
作者
Sims, TN
Afrouzian, M
Urmson, J
Zhu, LF
Halloran, PF [1 ]
机构
[1] Univ Alberta, Dept Med Microbiol & Immunol, Heritage Med Res Ctr 250, Edmonton, AB T6G 2S2, Canada
[2] Univ Alberta, Dept Med, Div Nephrol & Immunol, Heritage Med Res Ctr 250, Edmonton, AB T6G 2S2, Canada
[3] Univ Alberta, Dept Lab Med & Pathol, Heritage Med Res Ctr 250, Edmonton, AB T6G 2S2, Canada
[4] Univ Alberta, Dept Surg, Heritage Med Res Ctr 250, Edmonton, AB T6G 2S2, Canada
关键词
antigen presentation; Banff schema; CIITA; graft rejection; MHC regulation;
D O I
10.1034/j.1600-6143.2001.001003211.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Class II transactivator (CIITA) induces transcription of MHC class II genes, and induces class I in some cell lines. We examined the effect of CIITA deficiency on class I and II expression in mouse kidney. In CIITA knockout (CIITAKO) mice, basal class II was absent, but class I levels were mildly but significantly increased. Allogeneic stimulation or ischemic injury increased class I and II expression in kidneys of control (wild-type, WT) mice but induced only class I in CII-TAKO mice. Thus, in kidney, all basal and induced class II expression was CIITA-dependent, but neither basal nor induced class I was CIITA-dependent. Rejecting kidney allografts from CIITAKO mice in CBA hosts manifested intense induction of donor class I but no donor class II expression. Rejecting kidneys from both WT and CIITAKO donors showed predominantly CD8 T-cell infiltration at days 7 and 21, with increasing tubulitis and arteritis at day 21. CIITAKO kidneys showed fewer infiltrating cells than WT kidneys at day 21. Thus CIITA-deficient kidneys have no basal and induced class II expression but display intense induction of class I expression, and evoke typical rejection lesions, although some indices of infiltration are reduced at day 21.
引用
收藏
页码:211 / 221
页数:11
相关论文
共 45 条
[31]   Induction of MHC class I expression by the MHC class II transactivator CIITA [J].
Martin, BK ;
Chin, KC ;
Olsen, JC ;
Skinner, CA ;
Dey, A ;
Ozato, K ;
Ting, JPY .
IMMUNITY, 1997, 6 (05) :591-600
[32]   MASSIVE INDUCTION OF DONOR-TYPE CLASS-I AND CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS IN REJECTING CARDIAC ALLOGRAFTS IN THE RAT [J].
MILTON, AD ;
FABRE, JW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (01) :98-112
[33]   The Banff 97 working classification of renal allograft pathology [J].
Racusen, LC ;
Solez, K ;
Colvin, RB ;
Bonsib, SM ;
Castro, MC ;
Cavallo, T ;
Croker, BP ;
Demetris, AJ ;
Drachenberg, CB ;
Fogo, AB ;
Furness, P ;
Gaber, LW ;
Gibson, IW ;
Glotz, D ;
Goldberg, JC ;
Grande, J ;
Halloran, PF ;
Hansen, HE ;
Hartley, B ;
Hayry, PJ ;
Hill, CM ;
Hoffman, EO ;
Hunsicker, LG ;
Lindblad, AS ;
Marcussen, N ;
Mihatsch, MJ ;
Nadasdy, T ;
Nickerson, P ;
Olsen, TS ;
Papadimitriou, JC ;
Randhawa, PS ;
Rayner, DC ;
Roberts, I ;
Rose, S ;
Rush, D ;
Salinas-Madrigal, L ;
Salomon, DR ;
Sund, S ;
Taskinen, E ;
Trpkov, K ;
Yamaguchi, Y .
KIDNEY INTERNATIONAL, 1999, 55 (02) :713-723
[34]   Evidence for the in vivo role of class II transactivator in basal and IFN-gamma induced class II expression in mouse tissue [J].
Ramassar, V ;
Goes, N ;
Hobart, M ;
Halloran, PF .
TRANSPLANTATION, 1996, 62 (12) :1901-1907
[35]   KIDNEY-TRANSPLANTS IN MICE - ANALYSIS OF IMMUNE STATUS OF MICE BEARING LONG-TERM, H-2 INCOMPATIBLE TRANSPLANTS [J].
RUSSELL, PS ;
CHASE, CM ;
COLVIN, RB ;
PLATE, JMD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 147 (05) :1449-1468
[36]   IODINATION OF PROTEINS, GLYCOPROTEINS, AND PEPTIDES USING A SOLID-PHASE OXIDIZING-AGENT, 1,3,4,6-TETRACHLORO-3-ALPHA 6-ALPHA-DIPHENYL GLYCOLURIL (LODOGEN) [J].
SALACINSKI, PRP ;
MCLEAN, C ;
SYKES, JEC ;
CLEMENTJONES, VV ;
LOWRY, PJ .
ANALYTICAL BIOCHEMISTRY, 1981, 117 (01) :136-146
[37]   INCREASED MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGEN EXPRESSION IN UNILATERAL ISCHEMIC ACUTE TUBULAR-NECROSIS IN THE MOUSE [J].
SHOSKES, DA ;
PARFREY, NA ;
HALLORAN, PF .
TRANSPLANTATION, 1990, 49 (01) :201-207
[38]   In vivo class II transactivator expression in mice is induced by a non-interferon-γ mechanism in response to local injury [J].
Sims, TN ;
Goes, NB ;
Ramassar, V ;
Urmson, J ;
Halloran, PF .
TRANSPLANTATION, 1997, 64 (12) :1657-1664
[39]  
SOLEZ K, 1995, TRANSPL P, V27, P1009
[40]   Two levels of help for B cell alloantibody production [J].
Steele, DJR ;
Laufer, TM ;
Smiley, ST ;
Ando, Y ;
Grusby, MJ ;
Glimcher, LH ;
Auchincloss, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :699-703